July 5th 2025
Collaborations between academic and community cancer centers enhance access to care, with success in acute myeloid leukemia and precision oncology.
Remove Race From Equation Used to Assess Kidney Function, Researchers Say
September 23rd 2021Long-awaited reports released Thursday call for eliminating race in estimated glomerular filtration rate equations and point to alternatives in an effort to eliminate disparities in chronic kidney disease.
Read More
MRD Monitoring Useful Across Risk Groups in ALL
September 23rd 2021In a recent paper, researchers outlined the utility of minimal residual disease (MRD) among patient with acute lymphoblastic leukemia (ALL) and how its monitoring at specific timepoints has proven useful for stratifying patients and helping to ensure appropriate treatment decisionsMRD
Read More
Vaccine Myths Detected as Major Reason for Low Vaccination Rates Among Patients With MS
September 23rd 2021Misconceptions about the safety and necessity of vaccines were cited as the main reasons for lower-than-recommended vaccination rates among patients with multiple sclerosis (MS), according to new research.
Read More
Study Contradicts Other Research About Potentially Inappropriate Medications Among Older Adults
September 22nd 2021The current study found that those prescribed potentially inappropriate medications were actually less likely to revisit the emergency department within 30 days, in contrast to prior work.
Read More
Spotlighting Pandemic-Related Challenges, Data-Driven Solutions for Payers
September 21st 2021On this episode of Managed Care Cast, we address how delays in routine care and other aspects of the pandemic are affecting payer organizations today, and how technology innovations like natural language processing can work to empower key initiatives in population health and beyond.
Listen
States Late to Adopt PrEP Risk Falling Further Behind
September 18th 2021A new analysis of 2014-2018 data among all states plus Washington, DC, for those who have either indications for preexposure prophylaxis (PrEP) or current prescriptions for the preventive treatment, shows a widening gap in PrEP uptake, with states considered early adopters pulling ahead of those considered late adopters.
Read More
Guselkumab Associated With Improved HRQOL, Skin Manifestations in Patients With Psoriasis
September 18th 2021Treatment of guselkumab was found to be safe and effective in improving health-related quality-of-life (HRQOL) and skin manifestations of patients with moderate to severe psoriasis in a real-world setting.
Read More
Early Life Lower Respiratory Tract Infections May Increase OSA Risk in Children
September 17th 2021Children who experience lower respiratory tract infections early in their lives were shown to be at significantly greater risk of developing obstructive sleep apnea in the first 5 years of life.
Read More
MS Disability, Symptoms Are Worse in Non-White Patients, Study Finds
September 16th 2021Non-white patients with multiple sclerosis (MS), particularly African American and Hispanic American patients, were found to experience a higher level of overall disability and more severe symptoms, highlighting current disparities in this disease.
Read More
Study Clarifies Prevalence and Incidence of SMA in Japan
September 16th 2021An epidemiological investigation of spinal muscular atrophy (SMA) in Japan provided clarity on the genetic condition’s prevalence and incidence in the country and highlighted the importance of newborn screening for SMA
Read More
Dr Joseph Alvarnas: PCOC 2021 Brings Together a Wide Variety of Oncology Stakeholders
September 16th 2021The Patient-Centered Oncology Care® (PCOC) conference, taking place in a hybrid format September 23-24, 2021, provides a space for oncologists, payers, health care system leaders, and others to delve into different possibilities to improve care, according to Joseph Alvarnas, MD, of City of Hope, editor-in-chief of Evidence-Based Oncology™ and co-chair of the meeting.
Watch
High OOP Costs for Treatment of Psoriatic Disease Found in Medicare Beneficiaries
September 15th 2021Medicare beneficiaries with psoriasis and psoriatic arthritis were found to pay high annual out-of-pocket (OOP) costs for treatment, which researchers attributed to rising drug prices and reliance on co-insurance for patient cost-sharing.
Read More
Dr Joseph Alvarnas on the Speakers, Sessions to Watch at PCOC 2021
September 15th 2021Looking forward to the 10th anniversary of the Patient-Centered Oncology Care® (PCOC) conference, taking place in a hybrid format September 23-24, 2021, Joseph Alvarnas, MD, of City of Hope, editor-in-chief of Evidence-Based Oncology™, and co-chair of the meeting, discusses the takeaways that attendees can expect to hear about in the areas of patient care, payment and quality, and multidisciplinary collaboration among specialists.
Watch
Could Psychedelics Ease Mental Health Toll From COVID-19, Other Crises?
September 15th 2021The fallout from COVID-19 has spotlighted the limitations of US mental health care, prompting the question if alternative treatments—like psychedelics—could help address current and impending crises.
Read More
Assessing Lower-Than-Expected Health Care Utilization Trends in Early 2021
September 14th 2021On this episode of Managed Care Cast, we speak with the lead clinician of a study by the Epic Health Research Network and Kaiser Family Foundation, which found that routine medical care and hospital admissions remained below expected levels in the early months of 2021, marking the second consecutive year for such results.
Listen
Spotlighting Social, Emotional Needs in Underserved Populations With Cancer
September 14th 2021Psychological and emotional needs specific to populations with cancer are often overlooked in clinical research, including those of adolescents, young adults, immigrants, and people of lower socioeconomic status.
Read More
Improving Outcomes-Based Managed Entry Agreements for SMA Therapy
September 12th 2021Innovative therapies for rare diseases such as spinal muscular atrophy (SMA), when paid for by public budgets in the European Union and elsewhere, are often managed by agreements between payers and drug companies, but details can be hard to discern.
Read More
Alpha-Glucosidase Inhibitor Use in Type 2 Diabetes Linked With Increased Psoriatic Disease Risk
September 11th 2021Discontinued use and high dosage of alpha-glucosidase inhibitors in combination with metformin was shown to increase risk of psoriasis and psoriatic arthritis in patients with type 2 diabetes compared with those given only metformin.
Read More